Personalis, Inc. (PSNL) vs Veracyte, Inc. (VCYT)

Personalis, Inc. and Veracyte, Inc. are both Diagnostics & Research companies. Veracyte, Inc. is the larger, with a market value of $1.9B against $1.7B — 1.1× the size. Personalis, Inc. has negative trailing earnings, so its P/E is not meaningful; Veracyte, Inc. trades at 15.2×. Veracyte, Inc. grew revenue faster over the last twelve months: 17.5% against 16.9%. Veracyte, Inc. has the higher net margin (21.8% vs −147.7%) and the higher return on invested capital (4.33% vs −358.4%). Across the 17 metrics below, Veracyte, Inc. leads on 17 and Personalis, Inc. on 0.

Valuation

Metric PSNL VCYT Diagnostics & Research median
P/E n/m 15.16 34.52
P/S 20.71 3.34 4.24
P/B 7.86 1.35 3.42
Price to free cash flow n/m 11.98 33.51
EV/EBITDA n/m 11.76 23.44
EV/Sales 18.57 2.51 5.18
Earnings yield (7.50%) 6.59% (1.50%)
Free cash flow yield (6.35%) 8.34% 0.00%

Profitability

Metric PSNL VCYT Diagnostics & Research median
Gross margin 16.71% 71.98% 48.32%
Operating margin (156.66%) 17.08% (5.68%)
Net margin (147.74%) 21.80% (4.10%)
Free cash flow margin (120.79%) 27.84% 0.00%
Return on equity (62.14%) 9.43% 0.00%
Return on assets (44.66%) 8.63% (6.05%)
Return on invested capital (358.37%) 4.33% 0.00%

Growth

Metric PSNL VCYT Diagnostics & Research median
Revenue growth (TTM) 16.88% 17.50% 8.99%
EPS growth (last fiscal year) 33.58% 164.52% 20.36%
Revenue growth, 5-year CAGR (2.40%) 34.50% 7.30%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric PSNL VCYT Diagnostics & Research median
Debt to equity 0.00 0.00 0.01
Current ratio 4.53 5.56 2.27
Net debt to EBITDA 2.93 (5.44) 0.68

Dividend

Metric PSNL VCYT Diagnostics & Research median
Dividend yield — — 0.67%
Payout ratio — — 0.20

Size

Metric PSNL VCYT Diagnostics & Research median
Market cap 1.69b 1.93b 2.22b

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack